PATHAI
PathAIโs services solve challenging pathology problems faced by the research and pharmaceutical industry. The PathAI platform provides end-to-end automation for reliable, scalable, and cost-effective long-term solutions. PathAI is developing technology that assists pathologists in making rapid and accurate diagnoses for every patient, every time. The company was founded in 2016 and based in Boston, Massachusetts.
PATHAI
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2016-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.pathai.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
255.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2021-07-26 | Poplar Healthcare | Poplar Healthcare acquired by PathAI | N/A |
Investors List
General Atlantic
General Atlantic investment in Series C - PathAI
LabCorp
LabCorp investment in Series C - PathAI
General Catalyst
General Catalyst investment in Series C - PathAI
Adage Capital Management
Adage Capital Management investment in Series C - PathAI
Refactor Capital
Refactor Capital investment in Series C - PathAI
Kaiser Permanente
Kaiser Permanente investment in Series C - PathAI
Bienville Capital
Bienville Capital investment in Series C - PathAI
Biospring Partners
Biospring Partners investment in Series C - PathAI
Bristol Myers Squibb
Bristol Myers Squibb investment in Series C - PathAI
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Series C - PathAI
Newest Events participated
Key Employee Changes
Date | New article |
---|---|
2022-07-14 | PathAI Appoints Brandon Eldredge as Chief Financial Officer |
2021-10-22 | PathAI Welcomes Two New Executives as it Strengthens its Biopharma Business Leadership Team |
Official Site Inspections
http://www.pathai.com Semrush global rank: 1.83 M Semrush visits lastest month: 12.4 K
- Host name: 104.18.15.153
- IP address: 104.18.15.153
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "PathAI" on Search Engine
We Bring Powerful New Technologies to Pathology โฆ
Our mission at PathAI is to improve patient outcomes with AI-powered pathology through: More Accurate Diagnosis. Matching Patients with the Most Effective Treatments. More Life-Saving Drug Approvals. โฆSee details»
PathAI - Crunchbase Company Profile & Funding
PathAIโs services solve challenging pathology problems faced by the research and pharmaceutical industry. The PathAI platform provides end-to-end automation for โฆSee details»
The First Frontier for Medical AI Is the Pathology Lab
Nov 29, 2018 So says Andrew H. Beck, a pathologist by training who cofounded and runs a three-year-old startup called PathAI, based in Boston. He says his tools will bring real โฆSee details»
PathAI | LinkedIn
PathAI's mission is to improve patient outcomes with AI-powered pathology. Our platform promises substantial improvements to the accuracy of diagnosis and the efficacy of โฆSee details»
PathAI Announces Strategic Partnership with Roche to โฆ
Oct 15, 2021 PathAI is a leading provider of AI-powered research tools and services for pathology. PathAI's platform promises substantial improvements to the accuracy of โฆSee details»
PathAI Announces PathExplore, an AI-powered โฆ
Apr 4, 2023 PathAI's PathExploreโข panel will empower oncology drug developers with improved tumor microenvironment spatial characterization from H&E, propelling a new โฆSee details»
PathAI Announces New Executive Appointment to Drive โฆ
Jun 14, 2023 PathAI is the only AI-focused technology company to provide comprehensive precision pathology solutions from wet lab services to algorithm โฆSee details»
Roche announces PathAI collaboration for artificial โฆ
Oct 14, 2021 Collaboration with PathAI expands pathologist access to innovative AI-powered technology to support companion diagnostic and drug development programs. โฆSee details»
Case Study: PathAI Uses PyTorch to Improve Patient โฆ
Jul 15, 2022 PathAI develops machine learning models which provide insights for drug development R&D, for powering clinical trials, and for making diagnoses. To this end, โฆSee details»
PathAI โ Can we create a better, more robust pathologist
Nov 25, 2022 PathAI is a Boston-based digital pathology startup founded in 2016. They layer on AI to enable substantial improvements to the accuracy of pathological โฆSee details»
PathAI finds its way to $165M series C for diagnostic and drug ...
By Andrea Park May 19, 2021 9:10am. Artificial Intelligence diagnostics digital pathology drug development. If its hundreds of millions in venture funding and wide-ranging cadre โฆSee details»
PathAI on Empowering the Next Generation of Pathology - EnvZone
May 2, 2023 Since its founding in 2016, PathAI has grown rapidly, expanding its capabilities to include the development of digital pathology software and other AI-based โฆSee details»
PathAI to Present on AI Models Supporting Advances in โฆ
PathAI to Present on AI Models Supporting Advances in Oncology Research at Society for Immunotherapy of Cancer Annual Meeting. BOSTON, MA โ November 7, 2022 โ โฆSee details»
PathAI branches into clinical lab services with acquisition of โฆ
Jul 26, 2021 With its recent acquisition of Poplar Healthcare Management, the management service organization for lab services provider Poplar Healthcare, PathAI โฆSee details»
Roche enters into collaboration agreement with PathAI to expand โฆ
Feb 13, 2024 Roche. Under the terms of this agreement, PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop AI-enabled digital pathology algorithms in โฆSee details»
PathAI enters into clinical diagnostics through acquisition of โฆ
Jul 26, 2021 PathAI is a leading provider of AI-powered research tools and services for pathology. PathAI's platform promises substantial improvements to the accuracy of โฆSee details»
PathAI - Funding, Financials, Valuation & Investors - Crunchbase
PathAI develops technology that assists pathologists in making accurate diagnoses for every patient, every time.See details»
PathAI AI Models Oncology Research | Tissuepathology.com
Nov 8, 2022 PathAI will share five new posters, all developed in collaboration with biopharmaceutical partners, that highlight their new AI-model development to support โฆSee details»
PathAI Appoints Brandon Eldredge as Chief Financial Officer
BOSTON โ JULY 14, 2022 โ PathAI, a global leader in AI-powered pathology, today announced that it has appointed Brandon Eldredge as Chief Financial Officer.See details»
PathAI - Contacts, Employees, Board Members, Advisors
Organization. PathAI. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 12. Number of Board Member โฆSee details»